Skip to the page

Data / Form D filings / Lhotse Medical, Inc.

Lhotse Medical, Inc.: Form D filings

Lhotse Medical, Inc., a technology company in Dallas, TX, filed 2 Form D notices with the SEC between 2024 and 2025. The latest, on May 6, 2025, reports $1.5 million sold of a $1.5 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7557 BENEDICT DRIVE, Dallas, TX, 75214
Phone
(415) 851-0337
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2006837

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 6, 2025New notice$1,509,999$1,509,9994Apr 25, 2025sec.gov
Jan 4, 2024New notice$2,299,998$2,194,998$105,0007Dec 22, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Carter MeyerDirector
Chris KasterDirector
Anand DoraiswamyExecutive Officer, Director
Josh BaltzellDirector

Other technology companies in Texas that filed recently

Every Form D from the week of May 5, 2025 · All recent filings in Texas · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Lhotse Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.